Childhood Asthma in Urban Settings Clinical Research Network
- Award ceiling
- Not stated
- Closes
- Not stated
- Last verified
- 2026-10-29
Per-recipient award not stated for city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally recognized), native american tribal organizations (other than federally recognized tribal governments), nonprofits having a 501(c)(3) status with the irs, other than institutions of higher education, nonprofits that do not have a 501(c)(3) status with the irs, other than institutions of higher education, others (see text field entitled "additional information on eligibility" for clarification), private institutions of higher education, public and state controlled institutions of higher education, public housing authorities/indian housing authorities, small businesses, special district governments, state governments.
In one sentence
Childhood Asthma in Urban Settings Clinical Research Network does not state a per-recipient award amount, open to city or township governments, county governments, for profit organizations other than small businesses, independent school districts, native american tribal governments (federally…
- Program pool (total)
- $8,380,000Total across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- Not confirmed
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Not stated
- Deadline type
- Not stated
- Opens
- Jan 8, 2027
- Status
- Forecasted
- Eligible entities
- City or township governments · County governments · For profit organizations other than small businesses · Independent school districts · Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Private institutions of higher education · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · Small businesses · Special district governments · State governments
- Geography
- Not stated
- Matching funds
- No
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- development and testing of innovative hypotheses and strategies for asthma prevention · identification and testing of new treatment targets for asthma · exploration of risk relationship between upper and lower airway · identification of disease endotypes suitable for therapeutic modalities
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Who can apply?
+5more
, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governmentsNot confirmed
Source field: applicant size limitOther Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional…
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
What can the money be used for?
4 categorysThe source’s own spending categories, and what is not parsed.
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
How hard is the application?
1 fieldEffort, match requirement and reimbursement, as the source stated them.
- Application effort
- Not confirmed
- Disbursement
- Not confirmed
- Matching funds
- No
Who has received this funding?
15561 awardsAwards on file for this programme, counted rather than modelled.
15561 prior awards on file for this programme, largest first. Every row comes from the funder's own award listing; nothing here is estimated.
| Recipient | State | Amount | Fiscal year |
|---|---|---|---|
| METABOLITEDX CORP | Not stated | $306,500 | 2024 |
| MUCOMMUNE LLC | Not stated | $306,500 | 2022 |
| MUCOMMUNE LLC | Not stated | $306,500 | 2021 |
| PULMONESCENCE DIAGNOSTICS INC | Not stated | $306,500 | 2022 |
| QRONO, INC | Not stated | $306,500 | 2024 |
| AIMMAX THERAPEUTICS INC | Not stated | $306,497 | 2024 |
| MUCOMMUNE LLC | Not stated | $306,483 | 2023 |
| LYBRA BIO INC. | Not stated | $306,321 | 2025 |
| UNIVERSITY OF CHICAGO | Not stated | $306,233 | 2023 |
| UNIVERSITY OF CALIFORNIA SANTA CRUZ | Not stated | $306,096 | 2021 |
| ALEUTIAN THERAPEUTICS, INC. | Not stated | $305,855 | 2025 |
| PRESIDENT AND FELLOWS OF MIDDLEBURY COLLEGE | Not stated | $305,777 | 2020 |
| THE UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH | Not stated | $305,596 | 2017 |
| CONNECTICUT AGRICULTURAL EXPERIMENTAL STATION | Not stated | $305,054 | 2025 |
| SAINT LOUIS UNIVERSITY | Not stated | $305,000 | 2024 |
| TEXAS CHRISTIAN UNIVERSITY | Not stated | $304,907 | 2021 |
| KOMMODO HOLDINGS CORP. | Not stated | $304,838 | 2025 |
| LACTIGA US INC. | Not stated | $304,629 | 2025 |
| PROTABIT, LLC | Not stated | $304,602 | 2025 |
| VITALANT | Not stated | $304,509 | 2015 |
| THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER | Not stated | $304,272 | 2025 |
| DAY ZERO DIAGNOSTICS INC | Not stated | $303,932 | 2022 |
| ANTIGER THERAPEUTICS INC. | Not stated | $303,274 | 2025 |
| GATEWAY BIO INC | Not stated | $303,173 | 2025 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | Not stated | $302,718 | 2019 |
| AINCOBIO LLC | Not stated | $302,714 | 2022 |
| GENETAG TECHNOLOGY, INC | Not stated | $302,500 | 2023 |
| PROGENRA INC | Not stated | $302,421 | 2025 |
| TRPBLUE, INC. | Not stated | $302,320 | 2020 |
| MARPAM PHARMA LLC | Not stated | $302,248 | 2024 |
| NORTHEASTERN UNIVERSITY | Not stated | $302,198 | 2019 |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | Not stated | $301,609 | 2025 |
| KANSAS STATE UNIVERSITY | Not stated | $301,352 | 2022 |
| UNIVERSITY OF MARYLAND, BALTIMORE | Not stated | $301,274 | 2017 |
| UNIVERSITY OF WATERLOO | Not stated | $300,999 | 2019 |
| SHY THERAPEUTICS, LLC | Not stated | $300,616 | 2025 |
| WASHINGTON UNIVERSITY, THE | Not stated | $300,582 | 2017 |
| THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO | Not stated | $300,378 | 2018 |
| OHIO STATE UNIVERSITY, THE | Not stated | $300,300 | 2015 |
| SIMON FRASER UNIVERSITY | Not stated | $300,200 | 2018 |
| INTACT GENOMICS INC | Not stated | $300,156 | 2023 |
| ACCELEVIR DIAGNOSTICS LLC | Not stated | $300,000 | 2021 |
| ACCELEVIR DIAGNOSTICS LLC | Not stated | $300,000 | 2020 |
| ACCELEVIR DIAGNOSTICS LLC | Not stated | $300,000 | 2018 |
| ACEPRE, LLC | Not stated | $300,000 | 2021 |
| ACHEMINALL CORPORATION | Not stated | $300,000 | 2024 |
| AMBERSTONE BIOSCIENCES INC | Not stated | $300,000 | 2021 |
| ANALYTICAL DIAGNOSTIC SOLUTIONS INC | Not stated | $300,000 | 2023 |
| BELLBROOK LABS LLC | Not stated | $300,000 | 2019 |
| BIOMORPH TECHNOLOGIES LLC | Not stated | $300,000 | 2023 |
| BIOMORPH TECHNOLOGIES LLC | Not stated | $300,000 | 2021 |
| BIOTHERAPEUTICS, INC. | Not stated | $300,000 | 2024 |
| BIOTHERAPEUTICS, INC. | Not stated | $300,000 | 2021 |
| BIOTHERAPEUTICS, INC. | Not stated | $300,000 | 2021 |
| BOLDER BIOTECHNOLOGY INC | Not stated | $300,000 | 2021 |
| BRIGHAM & WOMENS HOSPITAL INC | Not stated | $300,000 | 2021 |
| CAPTIS DIAGNOSTICS INC. | Not stated | $300,000 | 2019 |
| CAROGEN CORP | Not stated | $300,000 | 2020 |
| CEDARS-SINAI MEDICAL CENTER | Not stated | $300,000 | 2008 |
| CELLERGY PHARMA INC. | Not stated | $300,000 | 2024 |
| CYRUS BIOTECHNOLOGY, INC | Not stated | $300,000 | 2025 |
| DAY ZERO DIAGNOSTICS INC | Not stated | $300,000 | 2021 |
| EFFECTORBIO, INC. | Not stated | $300,000 | 2023 |
| ELECTRONIC BIOSCIENCES, INC. | Not stated | $300,000 | 2023 |
| EMMUNE INC | Not stated | $300,000 | 2025 |
| ENYX THERAPEUTICS LLC | Not stated | $300,000 | 2022 |
| FORWARD DEFENSE, LLC | Not stated | $300,000 | 2022 |
| GEL4MED INC | Not stated | $300,000 | 2020 |
| GEL4MED INC | Not stated | $300,000 | 2019 |
| GENELANCET BIOSCIENCES INC | Not stated | $300,000 | 2022 |
| GENERAL NANOTHERAPEUTICS LLC | Not stated | $300,000 | 2022 |
| GIGAMUNE, INC. | Not stated | $300,000 | 2023 |
| HARLINGENE LIFE SCIENCES LLC | Not stated | $300,000 | 2022 |
| HASENTECH, INC. | Not stated | $300,000 | 2020 |
| HBVTECH, L.L.C | Not stated | $300,000 | 2021 |
| IMMPORT THERAPEUTICS INC | Not stated | $300,000 | 2025 |
| INDEE. INC. | Not stated | $300,000 | 2020 |
| IONIC PHARMACEUTICALS, LLC | Not stated | $300,000 | 2024 |
| JAN BIOTECH, INC. | Not stated | $300,000 | 2023 |
| LIFE PHARMS INC | Not stated | $300,000 | 2025 |
| LIFESENSORS INC | Not stated | $300,000 | 2020 |
| LUCERNA INC | Not stated | $300,000 | 2024 |
| MICRORID TECHNOLOGIES INC | Not stated | $300,000 | 2024 |
| NABGEN INC | Not stated | $300,000 | 2020 |
| OPTIMEOS LIFE SCIENCES, INC. | Not stated | $300,000 | 2024 |
| PAI LIFE SCIENCES INC | Not stated | $300,000 | 2023 |
| PEAK DIAGNOSTIC PARTNERS INC | Not stated | $300,000 | 2022 |
| QUERCUS MOLECULAR DESIGN, LLC | Not stated | $300,000 | 2020 |
| RUMI SCIENTIFIC, INC. | Not stated | $300,000 | 2023 |
| SCALED MICROBIOMICS LLC | Not stated | $300,000 | 2023 |
| SCRIBE BIOSCIENCES, INC. | Not stated | $300,000 | 2023 |
| SINGLETO2 THERAPEUTICS LLC | Not stated | $300,000 | 2024 |
| SIOLTA THERAPEUTICS INC | Not stated | $300,000 | 2023 |
| STINGINN, LLC | Not stated | $300,000 | 2022 |
| TECHNOVAX INC | Not stated | $300,000 | 2020 |
| TENDEL THERAPIES INC. | Not stated | $300,000 | 2020 |
| THE METHODIST HOSPITAL RESEARCH INSTITUTE | Not stated | $300,000 | 2025 |
| THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | Not stated | $300,000 | 2025 |
| THERAPYX, INC. | Not stated | $300,000 | 2022 |
| THIMBLE THERAPEUTICS INC | Not stated | $300,000 | 2022 |
Recipient names as published by the California Grants Portal.
What comparable notices state
293 recordsStated ceilings on open records in the same industry.
Among open records stored under Health & Human Services, 293 of 888 state an award ceiling. Those that do run:
- 25th percentile$350,000
- Median$600,000
- 75th percentile$1,500,000
A statistical estimate, not a prediction. It describes what a set of notices has published in this catalogue on the day you read it, and says nothing about what this programme will award. Records stating no ceiling are excluded rather than counted as zero, and the programme pool — what a funder has across every applicant — is a different column and is never mixed in.
Who has won this programme before?
15561 awardsAwards under the same assistance listing, not under this notice.
15561 federal awards on file under assistance listing 93.855, the programme this notice is published under. These are not awards made under this notice — a listing covers every year the programme runs, and awards under an open notice do not exist yet.
- $1,073,967,938FRED HUTCHINSON CANCER CENTERWA · FY2006
- $246,626,852PRESIDENT AND FELLOWS OF HARVARD COLLEGEMA · FY2006
- $201,437,825SCRIPPS RESEARCH INSTITUTECA · FY2019
- $197,316,803UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTONTX · FY2011
- $180,737,624DUKE UNIVERSITYNC · FY2013
Common questions
5 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- How much funding is available in total?
- $8,380,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
- Who is eligible to apply?
- City or township governments, County governments, For profit organizations other than small businesses, Independent school districts, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), Private institutions of higher education, Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities, Small businesses, Special district governments, State governments.
- What can the funding be used for?
- development and testing of innovative hypotheses and strategies for asthma prevention, identification and testing of new treatment targets for asthma, exploration of risk relationship between upper and lower airway, identification of disease endotypes suitable for therapeutic modalities, as classified by the source.
- Is matching funding required?
- No. The source states that no matching funds are required.
- Has this programme funded anyone before?
- 15561 prior awards are on file for this programme, made by National Institutes of Health. Recipients, amounts and fiscal years are listed on this page.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inWhat else is open
- Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)Closes Not statedAwards up to $600,000
- INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)Closes Not statedAwards Not stated
- The Next Generation of the Clinical and Translational Science Awards Program Trial Innovation NetworkCloses Not statedAwards Not stated
- Limited Competition: Clinical and Translational Science Awards (CTSA) Program: Collaborative and Innovative Acceleration AwardCloses Not statedAwards Not stated
- Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational ScienceCloses Not statedAwards Not stated
- Limited Competition: Research Education Program for the Clinical and Translational Science Awards ProgramCloses Not statedAwards Not stated
A listing names the programme; a notice names one round of it. These are other rounds open now, not other years of this one.
- Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV)Closes Not statedAwards Not stated
- Translational Transplantation Tolerance Cooperative Study GroupCloses Not statedAwards Not stated
- Clinical Data, Safety and Statistical Centers (CDSSC)Closes Not statedAwards Not stated
- Clinical Trials in Organ Transplantation in Children and AdultsCloses Not statedAwards Not stated
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)Closes Jan 29, 2027Awards Not stated
- Asthma and Allergic Diseases Cooperative Research CentersCloses Not statedAwards Not stated
The official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.